Clearstead Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8K | Hold |
825
| – | – | ﹤0.01% | 1766 |
|
|
2025
Q1 | $12.7K | Buy |
825
+808
| +4,753% | +$12.4K | ﹤0.01% | 1548 |
|
|
2024
Q4 | $375 | Hold |
17
| – | – | ﹤0.01% | 1997 |
|
|
2024
Q3 | $307 | Hold |
17
| – | – | ﹤0.01% | 1979 |
|
|
2024
Q2 | $277 | Buy |
+17
| New | +$277 | ﹤0.01% | 1967 |
|
|
2021
Q1 | – | Sell |
-75
| Closed | -$1K | – | 1177 |
|
|
2020
Q4 | $1K | Hold |
75
| – | – | ﹤0.01% | 957 |
|
|
2020
Q3 | $1K | Hold |
75
| – | – | ﹤0.01% | 862 |
|
|
2020
Q2 | $1K | Hold |
75
| – | – | ﹤0.01% | 771 |
|
|
2020
Q1 | $1K | Buy |
+75
| New | +$1K | ﹤0.01% | 759 |
|
|
2017
Q3 | – | Sell |
-9,461
| Closed | -$314K | – | 257 |
|
|
2017
Q2 | $314K | Buy |
9,461
+7
| +0.1% | +$232 | 0.05% | 177 |
|
|
2017
Q1 | $303K | Buy |
9,454
+1,926
| +26% | +$61.7K | 0.04% | 176 |
|
|
2016
Q4 | $273K | Buy |
+7,528
| New | +$273K | 0.04% | 175 |
|